Efficacy Trial of LJP 394 in Systemic Lupus Erythematosus

[Guest guest]

This email is being sent to notify you that the following new clinical

trial(s) in your selected area of interest have been recently posted

on the CenterWatch web site at http://www.centerwatch.com.

1) A Randomized, Double-Blind, Placebo-Controlled, Multicenter Safety

and Efficacy Trial of LJP 394 in Systemic Lupus Erythematosus (SLE)

Patients with a History of Renal Disease. This study is being

conducted in:

- Birmingham, AL (http://www.centerwatch.com/studies/stu23206.htm)

- Boston, MA (http://www.centerwatch.com/studies/stu23207.htm)

- Manhasset, NY (http://www.centerwatch.com/studies/stu23243.htm)

- Milwaukee, WI (http://www.centerwatch.com/studies/stu23209.htm)

- New Orleans, LA

(http://www.centerwatch.com/studies/stu23208.htm)

- St. Louis, MO (http://www.centerwatch.com/studies/stu23242.htm)